In 2024, the U.S. Drug Enforcement Administration (DEA) indicated that they intend to reclassify cannabis for a Program III drug. This rescheduling will identify that cannabis has genuine clinical uses and can help open up the door to study on other possible treatment method makes use of. From a pharmacological https://thcdisposables.co.uk/